James R Apgar - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

James R Apgar

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

The Journal of Biological Chemistry|February 2, 2020

Structure-function relationships of the soluble form of the antiaging protein Klotho have therapeutic implications for managing kidney diseaseXiaotian Zhong, Srinath Jagarlapudi, Yan Weng, et al.

Antibodies (Basel, Switzerland)|September 28, 2019

Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of CancerAdam R Root, Wei Cao, Bilian Li, et al.

Mabs|January 18, 2021

Discovery and optimization of a novel anti-GUCY2c x CD3 bispecific antibody for the treatment of solid tumorsAdam R Root, Gurkan Guntas, Madan Katragadda, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

The Journal of Biological Chemistry|February 2, 2020

Structure-function relationships of the soluble form of the antiaging protein Klotho have therapeutic implications for managing kidney diseaseXiaotian Zhong, Srinath Jagarlapudi, Yan Weng, et al.

Antibodies (Basel, Switzerland)|September 28, 2019

Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of CancerAdam R Root, Wei Cao, Bilian Li, et al.

Mabs|January 18, 2021

Discovery and optimization of a novel anti-GUCY2c x CD3 bispecific antibody for the treatment of solid tumorsAdam R Root, Gurkan Guntas, Madan Katragadda, et al.

Pageof 2